|4Dec 22, 2:31 PM ET

Booth Andrew 4

4 · AbCellera Biologics Inc. · Filed Dec 22, 2022

Insider Transaction Report

Form 4
Period: 2022-12-20
Booth Andrew
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Shares

    2022-12-20$0.19/sh+50,000$9,500188,500 total
  • Gift

    Common shares

    2022-12-2050,000138,500 total
  • Exercise/Conversion

    Share option (right to buy)

    2022-12-2050,0005,820,481 total
    Exercise: $0.19Exp: 2026-06-15Common shares (50,000 underlying)
Holdings
  • Common shares

    (indirect: By Spouse)
    130,959
Footnotes (2)
  • [F1]This transaction represents a charitable donation of 50,000 common shares the reporting person donated on December 20, 2022.
  • [F2]The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on June 15, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION